erythromycin (Compound)

Synonyms:erythromycin, 114-07-8, Erythromycin A, E-Mycin, Ilotycin, Abomacetin, Erymax, Erythromycinum, Emgel, Erycette, Robimycin, Erythro-Statin, E-Glades, Erythrocin, Ery-Tab, E-Base, Eritromicina, Erythromycine, Erygel, Sansac, Erythra-Derm, Akne-Mycin, ERYC, Erythromycin base, T-Stat, Eryacne, R-P Mycin, E-Solve 2, Torlamicina, Eryderm, C-Solve-2, Pantomicina, A/T/S, erythro, Erythroguent, Eritrocina, Propiocine, Stiemycin, Ermycin, Erycen, Aknin, Theramycin Z, erythromycin-A, Ak-Mycin, Erythromast 36, Benzamycin, Emycin, Erytab, Inderm, Retcin, (-)-ERYTHROMYCIN, CHEMBL532, Dumotrycin, Mephamycin, DTXSID4022991, CHEBI:42355, Wemid, J01FA01, Eryc Sprinkles, MFCD00084654, NSC-55929, 63937KV33D, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, Erythromycin C-13, Endoeritrin, Eritomicina, Erythroderm, Erytrociclin, Pharyngocin, Proterytrin, Acneryne, Acnesol, Aknemycin, Derimer, Deripil, Erisone, Eryacnen, Erydermer, Eryhexal, Erysafe, Iloticina, Latotryd, Lederpax, Mercina, Oftamolets, Pantoderm, Pantodrin, Primacine, Romycin, Stiemicyn, Tiprocin, Emuvin, Erecin, Erymed, Erytop, NCI-C55674, AustriaS, Eros, Ery-maxin, Erythro-Teva, Sans-acne, Erimycin-T, Ery-Diolan, Inderm Gel, Del-Mycin, Aknederm Ery Gel, Udima Ery Gel, Eryc 125, Emu-Ve, 8HPH7ND0LN, Skid Gel E, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione, Akne Cordes Losung, ERY, Ilosone (estolate), Ilotycin T.S., E-Mycin (base), Ery-Tab (base), Emu-V, Ery-B, E-Base (base), DTXCID102991, ERYC (base), N-Methylerythromycin A, PCE Dispertab (base), Eryc-125, Eryc-250, Eritromicina [INN-Spanish], Erythromycine [INN-French], Erythromycinum [INN-Latin], Erythromycin, labeled with carbon-13, Oftalmolosa Cusi Eritromicina, Staticin (TN), Akne-mycin (TN), Erygel (TN), Eryc (TN), T-stat (TN), Pce (TN), SR-05000001618, Sentry AQ mardel maracyn, 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, erthromycin, Erythromycines, NSC55929, CCRIS 9078, UNII-63937KV33D, HSDB 3074, NCGC00094670-01, Erythromycin [USP:INN:BAN:JAN], (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, CAS-114-07-8, Prestwick_205, EINECS 204-040-1, NSC 55929, 215031-94-0, 82343-12-2, Spectrum_000115, Spectrum_000659, AI3-50138, EM-A, Prestwick3_000151, Spectrum2_000759, Spectrum2_001263, Spectrum4_000538, Spectrum5_001596, UNII-8HPH7ND0LN, ERYTHROMYCIN [MI], E0751, ERYTHROMYCIN [INN], ERYTHROMYCIN [JAN], PCE (ERYTHROMYCIN), EC 204-040-1, ERYTHROMYCIN [HSDB], SCHEMBL2601, ERYTHROMYCIN [VANDF], BSPBio_000282, BSPBio_002480, ERYTHROMYCIN [MART.], KBioGR_001175, KBioSS_000555, KBioSS_001139, MLS001066618, BIDD:GT0017, DivK1c_000294, DivK1c_000397, DivK1c_000702, ERYTHROMYCIN [USP-RS], ERYTHROMYCIN [WHO-DD], ERYTHROMYCIN [WHO-IP], SPECTRUM1500280, SPBio_000778, SPBio_001226, BPBio1_000312, GTPL1456, Erythromycin (JP17/USP/INN), HMS500O16, KBio1_000294, KBio1_000397, KBio1_000702, KBio2_000555, KBio2_001139, KBio2_003123, KBio2_003707, KBio2_005691, KBio2_006275, ERYTHROMYCIN [GREEN BOOK], NINDS_000294, NINDS_000397, NINDS_000702, ERYTHROMYCIN [ORANGE BOOK], HMS1920M04, HMS2091D05, HMS2095O04, HMS3712O04, Pharmakon1600-01500280, ERYTHROMYCIN [EP MONOGRAPH], ACT03320, HY-B0220, RKL10096, ERYTHROMYCIN [USP MONOGRAPH], Tox21_111311, Tox21_111869, Tox21_300515, BDBM50344942, CCG-38992, LMPK04000006, NSC756759, ERYTHROMYCINUM [WHO-IP LATIN], AKOS015895249, DB00199, NSC-756759, BENZAMYCIN COMPONENT ERYTHROMYCIN, IDI1_000294, IDI1_000397, IDI1_000702, SMP1_000119, NCGC00179619-01, NCGC00179619-02, NCGC00179619-03, NCGC00254234-01, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, AC-12744, AC-12901, SMR000544946, ERYTHROMYCIN COMPONENT OF BENZAMYCIN, Erythromycin, potency: >=850 mug per mg, Erythromycin, tested according to Ph.Eur., SBI-0051368.P003, Erythromycin, N-demethyl-N-(methyl-11C)-, Erythromycin 1000 microg/mL in Acetonitrile, Erythromycin, meets USP testing specifications, C01912, D00140, E-3250, Erythromycin, plant cell culture tested, ~98%, AB00051981_09, AB00051981_10, Erythromycin, Biotechnology Performance Certified, Erythromycin estolate impurity, free erythromycin-, Q213511, SR-01000799155, Erythromycin, Antibiotic for Culture Media Use Only, Erythromycin, BioReagent, suitable for cell culture, SR-01000799155-2, SR-05000001618-1, SR-05000001618-2, BRD-K63550407-001-13-5, BRD-K63550407-028-03-9, Z2587996953, Erythromycin A, British Pharmacopoeia (BP) Reference Standard, Erythromycin A, European Pharmacopoeia (EP) Reference Standard, Erythromycin, United States Pharmacopeia (USP) Reference Standard, ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN [EP IMPURITY], ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN- [USP IMPURITY], Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard, Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione

Pubchem:PUBCHEM:12560

Id:e7f38b97-7a5a-5875-93b1-0bb65f8eebe8

Description:nan